Pfizer Covid-19 Vaccine Gains Full Approval from US FDA


The two-dose novel corona virus vaccine developed by Pfizer has now got the full permission from the UD FDA, and the vaccine has been first corona virus vaccine jab for getting the license in the United States, and the novel corona virus vaccine had initially been given the authorization of emergency use, and the two jabs of the Pfizer novel corona virus vaccine three weeks apart, and now fully it is completely permitted for the people between the age group of 16 years and older.

The acceptance of the vaccine has now been expected for setting off mandatory novel corona virus vaccines by the employers and the organizations across the United States, and the decision comes amid lingering the lingering of the novel corona virus vaccine hesitancy among most of the people in the United States.

The US FDA said, the review for the acceptance of the Pfizer covid-19 vaccine that has been included the data collected from around 44,000 people, and the novel corona virus vaccine, that is now going to be distributed as Comirnaty, which was founded to be 91 percent effective in the prevention of the novel corona virus disease.

READ  UK Trial, Symptoms of Parkinson’s Disease Reversed By Mini Implant

Janet Woodcock, acting commissioner of US FDA said, the people of the United States can be very confident that, the corona virus vaccine has now been meeting the high standards of effectiveness, safety and quality standards of manufacturing and the vaccine is still having the authorization for emergency use in the children coming between the age group of 12 to 15 years.